AZNAstraZenecaRunning, no new patients
A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer
Metastatic Colorectal Cancer
0Calmworry score, out of 100
No strong warning signs right now. The score counts warning signs; it is not a prediction.
Why this score
No warning signs right now. That's why the score is 0.
Score over time
- Stage
- Phase 2
- Patients
- 82 (final count)
- Started
- Mar 12, 2025
- Main results expected
- Jun 30, 2027
- Fully finished
- Sep 29, 2028
- Results posted
- not yet
What counts as success
The trial's main goal(s), called the “primary outcome.”
Progression Free Survival (PFS)
Measured over: Approximately 3 years
Number of Participants with Adverse Events (AEs)
Measured over: Approximately 3 years
Changes Tremor has spotted
No changes since Tremor started watching this trial.
Show details (technical version)
Score inputs
- none
Raw record changes
- none yet
Trial ID NCT06792695 · record last updated 2026-10-22 · checked 2026-11-09 15:47 UTC